SAP Announces Strategic Alliances to Drive Forward Genomic Research

WALLDORF — SAP AG today announced a strategic collaboration with Stanford School of Medicine to research the contribution of genetics, environmental exposures, behavior and other factors to disease susceptibility using the power of the SAP HANA platform. The company also announced its participation in the Global Alliance for Genomics and Health, a council of industry [...]

The General Shareholders’ Meeting of bioMérieux approves the appointment of two new independent directors

France -- The General Meeting of Shareholders of bioMérieux, a world leader in the field of in vitro diagnostics, today approved the appointment of two new independent directors, Agnès Lemarchand and Philippe Gillet. Agnès Lemarchand and Philippe Gillet were appointed to replace Georges Hibon and Michel Angé, who did not wish to renew their terms [...]

InSphero Launches 3D InSight™ Pancreatic Microislets for Diabetes and Toxicity Research

Schlieren, Switzerland -- InSphero AG today announced the launch of 3D InSight™ Human and Rat Pancreatic Microislets, further expanding the company’s catalog of organotypic 3D models produced using their patented hanging-drop production technology. The product launch follows InSphero‘s April publication of the microislets in theJournal of Tissue Engineering and Regenerative Medicine, characterizing their physiological properties [...]

BioTime’s Subsidiary Asterias Biotherapeutics, Inc. Settles Patent Interference Proceedings

MENLO PARK, Calif. & ALAMEDA, Calif.-- BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Asterias Biotherapeutics, Inc. (“Asterias”), announced that Asterias has entered into a settlement agreement with ViaCyte, Inc. (“ViaCyte”) concerning certain litigation in the United States District Court for the Northern District of California (Civil Action No. C12-04813) seeking the reversal of two [...]

Taconic Launches CRISPR Gene Editing Technology for Mouse and Rat Models

Hudson, New York – Taconic announced that it has officially launched CRISPR gene editing technology after receiving a license under certain patents from The Broad Institute. The Broad Institute patent represents the first granted patent for use of CRISPR technology in eukaryotic cells and is based on work by Dr. Feng Zhang in a paper [...]

Meridian Bioscience Receives Canadian Licenses for illumigene® Mycoplasma and illumigene® Pertussis

CINCINNATI -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received medical device license approval from Health Canada to market two additional assays for use on their illumigene® molecular diagnostic platform. With the addition of illumigene Mycoplasma and illumigene Pertussis, Meridian continues to expand its position in the Canadian market by [...]

Park Systems Collaborates with Semiconductor’s Leading Hard Disc Drive Manufacturers to Develop PTR Nanoscale Measurements that Increase Production Yields by 200 Percent

Santa Clara, CA -- Park Systems, a leading manufacturer of atomic force microscopy (AFM) products, proudly introduces itsnext generation NX-PTR, a fully automated system for hard disk drive slider manufacturing. Newly developed in collaboration with leaders in the hard disk drive (HDD) production, Park’s NX-PTR increases production yield by 200% with an enhanced automation routine, [...]

Agilent Technologies and SISCAPA Assay Technologies Provide Complete Solution for Targeted Multiplexed Protein Quantitation to Enhance Customer Workflows

SANTA CLARA, Calif., and WASHINGTON, D.C. -— Agilent Technologies Inc. (NYSE: A) and SISCAPA Assay Technologies (SAT) today announced they have signed a non-exclusive agreement to enable SAT to provide an end-to-end solution for multiplexed protein quantitation using a highly automated workflow for SISCAPA LC-mass spectrometry. This solution will combine SAT’s reagents for targeted protein [...]

GE Healthcare launches Cytiva™ Plus cardiomyocytes

GE’s most biologically relevant human cell model for improved compound safety profiling Identifying potential cardiotoxicity as early as possible in the drug development process can reduce the risk of costly program failures and minimize health risks. Cytiva™ Plus provides a high fidelity human heart cell model that is available in quantities compatible with screening, enabling [...]

Rancho BioSciences Announces That It is Now an Affiliate Member of the tranSMART Foundation and Will Commit Resources for Testing and Providing Content for tranSMART

San Diego, CA -- Rancho BioSciences, the scientific data consulting company, announced today that it is now an affiliate member of the tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive research data. Rancho BioSciences has donated 11 manually curated data sets to be used for testing [...]

Access IBO on Knowledge Center